Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page
- Check6 days agoChange DetectedThe study page now displays a 403 error, replacing the detailed record with an access-denied message. The content visible on the page no longer includes the study description, criteria, investigators, sponsors, or location details.SummaryDifference18%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6. This indicates a minor backend update to the study page version rather than a substantive change to the study details.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4. This update represents a small internal version change and does not alter study information or user-facing content.SummaryDifference0.1%

- Check63 days agoChange DetectedThe website revision was updated from v3.6.3 to v3.6.4, representing a newer platform release. There is no change to study data or page content reflected.SummaryDifference0.1%

- Check85 days agoChange DetectedThe revision indicator was updated from v3.6.2 to v3.6.3. This reflects an underlying site update but does not alter the study details or the information presented to users.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2. No user-facing content changes are indicated.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.